PROCEPT BioRobotics (PRCT) Operating Expenses (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Operating Expenses data on file, last reported at $86.6 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $86.6 million, up 20.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $315.0 million (up 24.7% YoY), and the FY2025 annual result was $300.1 million, up 28.4% from the prior year.
• Operating Expenses advanced to $86.6 million in Q1 2026 per PRCT's latest filing, from $77.4 million in the prior quarter.
• Over five years, Operating Expenses peaked at $86.6 million in Q1 2026 and troughed at $23.4 million in Q1 2022.
• A 5-year average of $54.0 million and a median of $52.7 million in 2024 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2026: Operating Expenses soared 89.8% in 2022, then climbed 20.89% in 2026.
• A 5-year view of Operating Expenses shows it stood at $35.7 million in 2022, then surged by 42.27% to $50.8 million in 2023, then rose by 24.74% to $63.4 million in 2024, then gained by 22.04% to $77.4 million in 2025, then climbed by 11.89% to $86.6 million in 2026.
• Business Quant data shows PRCT's Operating Expenses at $86.6 million in Q1 2026, $77.4 million in Q4 2025, and $77.2 million in Q3 2025.